Buscar

01/09/2022 Awareness of Diagnosis in Persons with Early-Stage Alzheimer's Disease: An Observational Study in Spain
Villarejo-Galende, A, Garcia-Arcelay, E, Pinol-Ripoll, G, del Olmo-Rodriguez, A, Vinuela, F, Boada, M, Franco-Macias, E, de la Pena, AI, Riverol, M, Puig-Pijoan, A, Abizanda-Soler, P, Arroyo, R, Baquero-Toledo, M, Feria-Vilar, I, Balasa, M, Berbel, A, Rodriguez-Rodriguez, E, Vieira-Campos, A, Garcia-Ribas, G, Rodrigo-Herrero, S, Lleo, A, Maurino, J. Awareness of Diagnosis in Persons with Early-Stage Alzheimer's Disease: An Observational Study in Spain. Neurology and Therapy. 2022; 11(3)DOI:10.1007/s40120-022-00367-3. PMID:35648383. IF:3.700(Q2/4D).
01/09/2022 Intermediate and Expanded HTT Alleles and the Risk for alpha-Synucleinopathies
Perez-Oliveira, S, Alvarez, I, Rosas, I, Menendez-Gonzalez, M, Blazquez-Estrada, M, Aguilar, M, Corte, D, Buongiorno, M, Molina-Porcel, L, Aldecoa, I, Marti, MJ, Sanchez-Juan, P, Infante, J, Gonzalez-Aramburu, I, Garcia-Gonzalez, P, Rosende-Roca, M, Boada, M, Ruiz, A, Perinan, MT, Macias-Garcia, D, Munoz-Delgado, L, Gomez-Garre, P, Mir, P, Clarimon, J, Lleo, A, Alcolea, D, De la Casa-Fages, B, Duarte, I, Alvarez, V, Pastor, P. Intermediate and Expanded HTT Alleles and the Risk for alpha-Synucleinopathies. MOVEMENT DISORDERS. 2022; 37(9)DOI:10.1002/mds.29153. PMID:35852957. IF:8.600(Q1/1D).
05/08/2022 Longitudinal Clinical and Cognitive Changes Along the Alzheimer Disease Continuum in Down Syndrome
Videla, L, Benejam, B, Pegueroles, J, Carmona-Iragui, M, Padilla, C, Fernandez, S, Barroeta, I, Altuna, M, Valldeneu, S, Garzon, D, Ribas, L, Montal, V, Martinez, JA, Aranha, MR, Alcolea, D, Bejanin, A, Iulita, MF, Ces, SV, Blesa, R, Lleo, A, Fortea, J. Longitudinal Clinical and Cognitive Changes Along the Alzheimer Disease Continuum in Down Syndrome. JAMA Network Open. 2022; 5(8)DOI:10.1001/jamanetworkopen.2022.25573. PMID:35930282. IF:13.800(Q1/1D).
01/08/2022 HDL-like-Mediated Cell Cholesterol Trafficking in the Central Nervous System and Alzheimer's Disease Pathogenesis
Borras, C, Mercer, A, Sirisi, S, Alcolea, D, Escola-Gil, JC, Blanco-Vaca, F, Tondo, M. HDL-like-Mediated Cell Cholesterol Trafficking in the Central Nervous System and Alzheimer's Disease Pathogenesis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(16)DOI:10.3390/ijms23169356. PMID:36012637. IF:5.600(Q1/3D).
27/07/2022 Network Tau spreading is vulnerable to the expression gradients of APOE and glutamatergic-related genes
Montal, V, Diez, I, Kim, CM, Orwig, W, Bueicheku, E, Gutierrez-Zuniga, R, Bejanin, A, Pegueroles, J, Dols-Icardo, O, Vannini, P, El-Fakhri, G, Johnson, KA, Sperling, RA, Fortea, J, Sepulcre, J. Network Tau spreading is vulnerable to the expression gradients of APOE and glutamatergic-related genes. Science Translational Medicine. 2022; 14(655)DOI:10.1126/scitranslmed.abn7273. PMID:35895837. IF:17.100(Q1/1D).
01/07/2022 Establishing In-House Cutoffs of CSF Alzheimer's Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort
Orellana, A, Garcia-Gonzalez, P, Valero, S, Montrreal, L, de Rojas, I, Hernandez, I, Rosende-Roca, M, Vargas, L, Tartari, JP, Antonio, EED, Bojaryn, U, Narvaiza, L, Alarcon-Martin, E, Alegret, M, Alcolea, D, Lleo, A, Tarraga, L, Pytel, V, Cano, A, Marquie, M, Boada, M, Ruiz, A. Establishing In-House Cutoffs of CSF Alzheimer's Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(13)DOI:10.3390/ijms23136891. PMID:35805894. IF:5.600(Q1/3D).
14/06/2022 Cerebral Amyloid Angiopathy-Related Inflammation in Down Syndrome-Related Alzheimer Disease
Aranha, MR, Fortea, J, Carmona-Iragui, M. Cerebral Amyloid Angiopathy-Related Inflammation in Down Syndrome-Related Alzheimer Disease. NEUROLOGY. 2022; 98(24)DOI:10.1212/WNL.0000000000200704. PMID:35470138. IF:9.900(Q1/1D).
03/06/2022 Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups
Kaivola, K, Shah, Z, Chia, R, Scholz, SW, Alcolea, D., Clarimón, J., Fortea, J., Lleó, A., Int LBD Genomics Consortium. Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups. BRAIN. 2022; 145(5)DOI:10.1093/brain/awab402. PMID:35381062. IF:14.500(Q1/1D).